Skip to main content
SpringerLink
Log in

Mechanisms, Hypotheses and Questions Regarding Prostate Cancer Micrometastases to Bone

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

The morbidity and mortality associated with prostate cancer can almost universally be attributed to the consequences of metastases to the bone. While clinically there have been descriptive reports of these lesions and their detection by bone scan, there is an embrrassing paucity of reports as to the mechanisms of prostate cancer cell trafficking to the bone, adaptation to the bone environment, pertubation of the normal bone reformation process and the events leading to cachexia and death. In recent years, there have been numerous in vitro studies suggesting that PSA and hK2 may play a significant biological role in these events. Also, recent data generated form reverse transcription polymerase chain reaction assays reveal that metastasis to the bone may be an early event which further underscores the need to better understand this complex and critically important process. This commentary highlights several general concepts and a few specific issues related to CaP bone metastasis with the intent of revealing numerous opportunities for further investigation and inquiry.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Walther HE, Krebsmetastase A. Basel: Beno Schwabe & Co. 1948

  2. Cook GB, Watson FR: Events in the natural history of prostate cancer: using salvage curves, mean age distributions and contingency. J Urol 96: 87-96, 1968

    Google Scholar 

  3. Cumming J, Hacking N, Fairhurst J, Ackery D, Jenkins JD: Distribution of bony metastases in prostatic carcinoma. Br J Urol 66: 411-414, 1990

    PubMed  Google Scholar 

  4. Rana A, Chisholm GD, Khan M, Sekharjit SS, Merrick MV, Elton RA: Patterns of bone metastasis and their prognostic significance in patients with carcinoma of the prostate. Br J Urol 72: 933-936, 1993

    PubMed  Google Scholar 

  5. Thalmann G, Anezinis P, Devoll R, Farach-Carson C, Chung LWK: Experimental approaches to skeletal metastasis of human prostate cancer. In: Raghavan D, Scher HI, Leibel SA and Lange PH (eds) Principles and practices of genitourinary oncology, Lippincott-Raven, Philadelphia, 1997, pp 409-416

    Google Scholar 

  6. Ewing JA: Treatise on Tumors. WB Saunders, Philadelphia, 1928

    Google Scholar 

  7. Talmadge JE, Fidler IJ: Cancer metastasis is selective or random depending on the parent tumour population. Nature 297: 593-596, 1982

    PubMed  Google Scholar 

  8. Yoneda T: Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 34: 240-245, 1998

    Article  PubMed  Google Scholar 

  9. Scher HI, Chung LWK: Bone metastases: improving the therapeutic index. Semin Oncol 21: 630-656, 1994

    PubMed  Google Scholar 

  10. Shevrin DH, Kukreja SC: Pathophysiology of human prostate cancer metastasis to bone, studied in vitroand in animal models. In: Bone Metastasis - Mechanisms and Pathophysiology. R.G. Landes Company, Austin, pp 181-194

  11. Stearns ME, Wang M: Bone metastases and prostate cancer. In: Bone Metastasis - Mechanisms and Pathophysiology, R.G. Landes Company, Austin, 1996, pp 195-220

    Google Scholar 

  12. Corey E, Corey MJ: Detection of disseminated prostate cells by reverse transcription-polymerase chain reaction (RT-PCR): technical and clinical aspects. Int J Cancer 77: 655-673, 1998

    Article  PubMed  Google Scholar 

  13. De la Taille A, Olsson CA, Katz AE: RT-PCR for PSA - Molecular staging of prostate cancer: Dream or reality? Oncology, 1999 (in press)

  14. Wood DP, Banks ER, Humphreys S, McRoberts JW, Rangnekar VM: Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 74: 2533-2540, 1994

    PubMed  Google Scholar 

  15. Melchior SW, Corey E, Ellis WJ, Ross AA, Layton TJ, Oswin MM, Lange PH, Vessella RL: Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin Cancer Res 3: 249-256, 1997

    PubMed  Google Scholar 

  16. Gao C, Dean RC, Pinto A, Mooneyhan R, Connelly RR, McLeod DG, Srivastava S, Moul JW: Detection of circulating PSA-expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). J Urol 1999 (in press)

  17. Hauschka PV, Manrakos AE, Iafrati MD, Doleman SE, Klagsbrun M: Growth factors in bone matrix. Isolation of multiple types of affinity chromatography on heparin sepharose. J Biol Chem 261: 12665-12674, 1986

    PubMed  Google Scholar 

  18. Pfeilschifter J, Mundy GR: Modulation of transforming growth factor beta activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci USA 84: 2024-2028, 1987

    PubMed  Google Scholar 

  19. Orr W, Varani J, Gondek MD, Ward PA, Mundy GR: Chemotactic responses of tumor cells to products of resorbing bone. Science 203: 176-179, 1979

    PubMed  Google Scholar 

  20. Orr FW, Varani J, Gondek MD, Ward PA, Mundy GR: Partial characterization of a bone derived chemotactic factor for tumor cells. Am J Pathol 90: 43-52, 1980

    Google Scholar 

  21. Pfeilschifter J, Wolf O, Naumann A, Minne HW, Mundy GR, Ziegler R: Chemotactic response of osteoblast-like cells to transforming growth factor beta. J Bone Miner Res 5: 825-830, 1990

    PubMed  Google Scholar 

  22. Manishen JW, Sivananthan K, Orr FW: Resorbing bone stimulates tumor cell growth: a role for the host microenvironment in bone metastasis. Am J Pathol 123: 39-45, 1986

    PubMed  Google Scholar 

  23. Boyde A, Maconnachie E, Reid SA, Delling G, Mundy GR: Scanning electron microscopy in bone pathology: review of methods. Potential and applications. Scanning Electron Microsc 4: 1537-1554, 1986

    Google Scholar 

  24. Hiraga T, Nakajima T, Ozawa H: Bone resorption induced by a metastatic human melanoma cell line. Bone 16: 349-356, 1995

    Article  PubMed  Google Scholar 

  25. Gutman EB, Sproul EE, Gutman AB: Significance of increased phosphatase activity of bone at the site of osteoplastic metastases secondary to carcinoma of the prostate gland. Am J Cancer 28: 485-495, 1998

    Google Scholar 

  26. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW: Human Kallikrein 2 (hK2) and prostate specific antigen (PSA): Two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 35: 275-368, 1998

    PubMed  Google Scholar 

  27. Cramer SD, Chen Z, Peehl DM: Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts. J Urology 156: 526-531, 1996

    Article  Google Scholar 

  28. Cohen P, Graves H, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG: Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 prostease found in seminal plasma. J Clin Endocrinol Metab 73: 1046-1052, 1992

    Article  Google Scholar 

  29. Plymate SR, Rosen CJ, Paulsen CA, Ware JL, Chen J, Vessella RL, Birnbaum RS: Proteolysis of insulin-like growth factor-binding protein-3 in the male reproductive tract. J Clin Endocrinol Metab 81: 618-624, 1996

    Article  PubMed  Google Scholar 

  30. Ide H, Katoh M, Sasaki H, Yoshida T, Aoki K, Nawa Y, Osada Y, Sugimura T, Terada M: Cloning of human bone morphogenetic protein type IB rceptor (BMPR-IB) and its expression in prostate cancer in comparison with other BMPRs [published erratum appears in Oncogene 1997 Aug 28; 15(9): 1121]. Oncogene 14: 1377-1382, 1997

    Article  PubMed  Google Scholar 

  31. Harris SE, Harris MA, Mahy P, Wozney J, Feng JQ, Mundy GR: Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate 24: 204-211, 1994

    PubMed  Google Scholar 

  32. Bentley H, Hamdy FC, Hart KA, Seid JM, Williams JL, Johnstone D, Russell RGG: Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer 66: 1159-1163, 1992

    PubMed  Google Scholar 

  33. Hienert G, Kirchheimer JC, Pfluger H, Binder BR: Urokinase-type plasminogen activator as a marker for the formation of distant metastases in prostatic carcinomas. J Urol 140: 1466-1469, 1988

    PubMed  Google Scholar 

  34. Soff G, Sanderowitz J, Gately S, Verrusio E, Weiss I, Brem S, Kwaa H: Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model. J Clin Invest 96: 2593-2600, 1995

    PubMed  Google Scholar 

  35. Achbarou A, Kaiser S, Tremblay G, Ste Marie LG, Brodt P, Goltzman D, Rabbani SA: Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res 54: 2372-2377, 1994

    PubMed  Google Scholar 

  36. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD: Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 90: 5021-5025, 1993

    PubMed  Google Scholar 

  37. Liu DF, Rabbani SA: Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC-3. Prostate 27: 269-276, 1995

    PubMed  Google Scholar 

  38. Rabbani SA: Urokinase (uPA) as a mediator of osteoblastic skeletal metastasis. In: Bone Metastasis - Mechanisms and Pathophysiology, R.G. Landers Company, Austin, 1996, pp 137-162.

    Google Scholar 

  39. Russell PJ, Bennett S and Stricker P: Growth factor involvement in progression of prostate cancer. Clin Chem 44: 705-723, 1998

    PubMed  Google Scholar 

  40. Tisdale MJ: Biology of cachexia. J Natl Cancer Inst 89: 1763-1773, 1997

    Article  PubMed  Google Scholar 

  41. Chou E and Simons JW: The molecular biology of prostate cancer morbidity and mortality: accelerated death from ejaculate poisoning? Urol Oncol 3: 79-84, 1997

    Google Scholar 

  42. Polascik TJ, Wang Z, Di S, Gurganus RT, Hortopan SC, Eisenberger MA, Carducci MA, OP T's P, Partin AW: Harvest of intact prostate cancer cells from blood: further characterization of a new assay. J Urol 159: 7, 1998 (Abstract)

    Google Scholar 

  43. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, Uhr JW: Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 95: 4589-4594, 1998

    Article  PubMed  Google Scholar 

  44. Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF, Yang H, Zhau HE, Balian G, Chung LW: Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 77: 887-894, 1998

    Article  PubMed  Google Scholar 

  45. Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, Brothman AR, Lamb DJ, Marcelli M, Belldegrun A, Witte ON, Sawyers CL: Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 3: 402-408, 1997

    Article  PubMed  Google Scholar 

  46. Quinn JE, Buhler KR, Brown JM, Bladou E, Lange PH, Vessella RL: A model for prostate cancer bone metastasis: Direct intra-bone injection of prostate cancer xenografts. Bone 23: S579, 1998 (Abstract)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Washington, Seattle, WA, USA

    Paul H. Lange & Robert L. Vessella

Authors
  1. Paul H. Lange
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert L. Vessella
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lange, P.H., Vessella, R.L. Mechanisms, Hypotheses and Questions Regarding Prostate Cancer Micrometastases to Bone. Cancer Metastasis Rev 17, 331–336 (1998). https://doi.org/10.1023/A:1006106209527

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006106209527

Search

Navigation